NCT06667206View on ClinicalTrials.gov

Earlier Prime-BOOST Schedule to Improve MEasles Protection in High Burden Settings

PHASE2RecruitingINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

November 15, 2023

Primary Completion Date

May 10, 2026

Study Completion Date

May 10, 2026

Conditions
Measles
Interventions
BIOLOGICAL

Licenced Measles-Rubella vaccine

Licenced Measles-Rubella vaccine provided by the Ugandan EPI programme

Trial Locations (1)

Unknown

RECRUITING

Makarere University - Johns Hopkins University Collaboration, Kampala

All Listed Sponsors
collaborator

St George's, University of London

OTHER

collaborator

MU-JHU CARE

OTHER

lead

University of Oxford

OTHER